Nurse Practitioner, Adult Health · Lake City, FL
NPI
1114609161
Since 2023
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4367 NW American Ln
Lake City, FL, 32055
Phone (386) 758-6094
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
1,631 services
Medicare patients, 2024
898
Average age 74
Drug cost, 2024
$528K
2,072 prescriptions
Company payments, 2025
$1,356
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel Groves was code 99214 (office e&m - established), 1,582 times for 858 patients. In total Rachel Groves billed 1,631 services in 5 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,582 | 858 | $76.56 | $121K |
| 99213 Office E&M - Established | Office | 41 | 41 | $47.03 | $1,928 |
By year: 2023 $27K for 333 services; 2024 $124K for 1,631 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel Groves prescribed most often to Medicare patients was Omeprazole, with 353 prescriptions and refills. In total Rachel Groves wrote 2,072 Medicare prescriptions that cost $528K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 353 | 799 | 157 | $5,051 |
| Famotidine Generic | 296 | 612 | 114 | $4,123 |
| Pantoprazole Sodium Generic | 265 | 605 | 106 | $2,911 |
| Linzess Linaclotide | 159 | 197 | 55 | $105K |
| Sucralfate Generic | 96 | 126 | 40 | $4,663 |
| Ondansetron Hcl Generic | 79 | 101 | 52 | $991 |
| Lubiprostone Generic | 78 | 118 | 29 | $9,130 |
| Ondansetron Odt Ondansetron | 69 | 113 | 30 | $2,586 |
| Voquezna Vonoprazan Fumarate | 67 | 75 | 22 | $48K |
| Lactulose Generic | 67 | 83 | 40 | $1,494 |
| Cholestyramine Cholestyramine (With Sugar) | 62 | 107 | 33 | $4,486 |
| Metoclopramide Hcl Generic | 58 | 70 | 20 | $320 |
| Dicyclomine Hcl Generic | 56 | 83 | 19 | $1,053 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 41 | 41 | 40 | $970 |
| Creon Lipase/Protease/Amylase | 34 | 49 | 17 | $107K |
Brand drugs: 393 claims; generic drugs: 1,679 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel Groves $1,356 ($1,356 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $243.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $243 |
| Phathom Pharmaceuticals, Inc. PHAT | 29 | $238 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $175 |
| Aimmune Therapeutics, Inc. | 7 | $162 |
| Ardelyx, Inc. ARDX | 6 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $107 |
| Janssen Biotech, Inc. JNJ | 3 | $88.57 |
| Pfizer Inc. PFE | 3 | $63.84 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $40.99 |
| Novo Nordisk Inc NVO | 1 | $30.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.